These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37862078)

  • 1. Variation in Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among US Men Who Have Sex with Men: A Latent Class Analysis.
    Beckham SW; Sanchez T; Fowler R; Zlotorzynska M; Rai M; Sullivan P; Vannappagari V; Sarkar S; Glick JL; Rinehart AR; Rawlings K; Bridges JFP
    AIDS Patient Care STDS; 2023 Oct; 37(10):495-503. PubMed ID: 37862078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment.
    Cole SW; Glick JL; Campoamor NB; Sanchez TH; Sarkar S; Vannappagari V; Rinehart A; Rawlings K; Sullivan PS; Bridges JFP
    BMJ Open; 2024 Apr; 14(4):e083837. PubMed ID: 38653510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying HIV PrEP Attributes to Increase PrEP Use Among Different Groups of Gay, Bisexual, and Other Men Who Have Sex with Men: A Latent Class Analysis of a Discrete Choice Experiment.
    Dawit R; Predmore Z; Raifman J; Chan PA; Skinner A; Napoleon S; Zanowick-Marr A; Le Brazidec D; Almonte A; Dean LT
    AIDS Behav; 2024 Jan; 28(1):125-134. PubMed ID: 37474623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.
    Zhao R; Fairley CK; Cook AR; Phanuphak N; He S; Tieosapjaroen W; Chow EPF; Phillips TR; Jin Tan RK; Wei Y; Shen M; Zhuang G; Ong JJ; Zhang L
    Lancet Glob Health; 2024 Feb; 12(2):e243-e256. PubMed ID: 38245115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM; Atujuna M; Browne EN; Ndwayana S; Hartmann M; Sindelo S; Ngcwayi N; Boeri M; Mansfield C; Bekker LG; Montgomery ET
    J Int AIDS Soc; 2020 Jun; 23(6):e25528. PubMed ID: 32544303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment.
    Dubov A; Ogunbajo A; Altice FL; Fraenkel L
    AIDS Care; 2019 May; 31(5):545-553. PubMed ID: 30554519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition.
    Lorenzetti L; Dinh N; van der Straten A; Fonner V; Ridgeway K; Rodolph M; Schaefer R; Schmidt HA; Baggaley R
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26107. PubMed ID: 37439057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived access to PrEP as a critical step in engagement: A qualitative analysis and discrete choice experiment among young men who have sex with men.
    Asiago-Reddy EA; McPeak J; Scarpa R; Braksmajer A; Ruszkowski N; McMahon J; London AS
    PLoS One; 2022; 17(1):e0258530. PubMed ID: 35081116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia.
    Paudel K; Gupta S; Gautam K; Wickersham JA; Khati A; Azwa I; Ha T; Shrestha R
    J Community Health; 2023 Jun; 48(3):513-521. PubMed ID: 36732459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferences for long-acting pre-exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey.
    Hsu JH; Ku SW; Chen TW; Li CW; Huang P; Wu HJ; Bourne A; Strong C
    J Int AIDS Soc; 2023 Sep; 26(9):e26163. PubMed ID: 37675767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for a community pharmacy-based pre-exposure prophylaxis (PrEP) delivery program: A discrete choice experiment.
    Goswami S; Bentley JP; Kang M; Bhattacharya K; Barnard M
    J Am Pharm Assoc (2003); 2024; 64(4):102091. PubMed ID: 38604477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferences Among Physicians and Men Who Have Sex with Men (MSM) for a Long-Acting, Removable Implant for HIV Prevention: A Discrete Choice Study.
    Tagliaferri Rael C; Giguere R; Sutton S; Horn E; Schieffer RJ; Greene GJ; D'Aquila R; Bryndza Tfaily E; Kiser PF; Hope TJ
    AIDS Res Hum Retroviruses; 2022 Dec; 38(12):898-908. PubMed ID: 36178358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferences Across Pre-Exposure Prophylaxis Modalities Among Young Men Who Have Sex with Men in the United States: A Latent Class Analysis Study.
    Valente PK; Bauermeister JA; Lin WY; Silva DTD; Hightow-Weidman L; Drab R; Mayer KH; Operario D; Rusley J; Biello KB
    AIDS Patient Care STDS; 2022 Nov; 36(11):431-442. PubMed ID: 36367995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine.
    Dubov A; Fraenkel L; Yorick R; Ogunbajo A; Altice FL
    AIDS Behav; 2018 Apr; 22(4):1100-1112. PubMed ID: 29214409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men.
    Dean LT; Predmore Z; Skinner A; Napoleon S; Chan PA; Raifman J
    AIDS Behav; 2023 Aug; 27(8):2606-2616. PubMed ID: 36670210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.
    Sullivan PS; Sanchez TH; Zlotorzynska M; Chandler CJ; Sineath RC; Kahle E; Tregear S
    J Int AIDS Soc; 2020 Mar; 23(3):e25461. PubMed ID: 32153119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study.
    Liu Y; Chu Z; Wang H; Huang X; Chen Y; Wang H; Zou D; Jiang Y; Geng W; Hu Q; Zhou B; Shang H
    BMC Public Health; 2023 Dec; 23(1):2494. PubMed ID: 38093204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis.
    Blair HA
    Drugs; 2022 Sep; 82(14):1489-1498. PubMed ID: 36255686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferences for Long-Acting and Alternative Modalities for PrEP among Military Men Who Have Sex with Men: Segmentation Results of an Adaptive Choice-Based Conjoint Analysis Study.
    Gutierrez JI; Vlahov D; Dubov A; Altice FL
    J Urban Health; 2022 Apr; 99(2):277-292. PubMed ID: 35318573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.